The Oncology Institute logo

Ammar Yousif, M.D.

Dr. Ammar Yousif
Rated 5 / 5 stars
Excellent service always.
Very knowledgeable medical staff

Languages Spoken

English, Arabic


Las Vegas
(702) 342-1244

2911 N. Tenaya Way
Suite 210
Las Vegas, NV 89128

(702) 577-2542


Ammar Yousif, M.D. is a Hematologist and Medical Oncologist. He received his medical degree from Baghdad University College of Medicine. He completed his internal medicine residency at the University of Nevada Las Vegas. His hematology and oncology fellowship was completed at the University of Arizona in Tucson, AZ.

Dr. Yousif began his medical career in 2006 with the Baghdad Medical Center as part of a pre-graduation internship. Beginning in 2013, Dr. Yousif worked as a research assistant for the MD Anderson Cancer Center at the University of Texas in Houston. Throughout his career, Dr. Yousif has been published several times in multiple peer reviewed journal articles.

Professional Memberships

  • American Society of Hematology (ASH)
  • American Society of Clinical Oncology (ASCO)
  • Health Outreach of the Middle East


  • A. Yousif, H. Cui, S. Russell, A Larsen and K. Gowin. Risk of infection associated with daratumumab treatment for Multiple Myeloma: American Journal of Hematology. Lymphoma, Leukemia and Myeloma Congress 2020
  • Chaftari AM, Jordan M, Hachem R, Al Hamal Z, Jiang Y, Yousif A, Garoge K, Deshmukh P, Raad I.. A clinical practical approach to the surveillance definition of central line-associated bloodstream infection in cancer patients with mucosal barrier injury.AJIC. 2016.
  • A. Yousif, A. Chaftari, M. Michael, M. Jordan, Z. Al Hamal, A. Hussain, N. Elizabeth, Y. Jiang, R. Hachem, I. Raad. The influence of using antibiotic-coated peripherally inserted central catheters on decreasing the risk of central line-associated bloodstream infections. American journal of infection control, 2016.
  • A Yousif, MA Jamal, I Raad. Biofilm-based central line-associated bloodstream infections. Biofilm-based healthcare-associated infections, 2015.
  • A. Chaftari, R. Hachem, R. Reitzel, M. Jordan, Y. Jiang, A. Yousif, K. Garoge, P. Deshmukh, Z. Al Hamal, J. Jabbour, A. Hanania, S. Raad, M. Jamal, I. Raad. Role of procalcitonin and interleukin-6 in predicting cancer, and its progression independent of infection. PloS one, 2015.
Skip to content